How the body's age affects bone-strengthening treatment for osteoporosis
Part of Bones, joints & muscles, Hormones & metabolism clinical trials.
This study looks at how the natural aging of the body might affect how well bone-strengthening medications work for osteoporosis. If you are about to start one of these medications, the study will track your bone density over time to see how your response may differ based on your 'biological age.'
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 50 years old.
- You have been diagnosed with osteoporosis (by a bone density test) or have had a bone fracture from a minor fall.
- You are planning to start a bone-strengthening medication (such as denosumab or a bisphosphonate) as part of your regular care.
- You must be willing to have bone density tests, both at the start of the study and during follow-up.
- You are not currently being treated for diabetes (type 1 or type 2).
- You do not have chronic kidney disease or a history of cancer in the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an osteoporosis medication can help preserve muscle strength in older adults who live in senior facilities. It's for people age 65+ with fragile bones or low bone density who are at risk for falls and fractures.
This study looks at how well your bones and muscles work together. By measuring your bone density and handgrip strength, doctors can better understand your bone health and find ways to keep you strong as you age.
This trial tests whether switching between two medications (Romosozumab and Denosumab) using a cycle or sequence schedule works better for improving bone density in postmenopausal women with severe osteoporosis. It aims to find the most effective treatment plan.
This study tests a structured bone health improvement program for adults over age 40 who are attending a health checkup at the hospital. It aims to improve or maintain bone strength, using bone density measurements as part of the study.
This study tests an investigational injection called TST002 to see if it can help strengthen bones in postmenopausal women with osteoporosis or low bone mass. It may help reduce the risk of fractures.
This study tests whether a daily probiotic supplement can help prevent bone loss in adults aged 60 and older. It is designed for people who have chosen not to take standard osteoporosis medications.
Hear when a new Osteoporosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.